This effect is believed to be mediated by augmenting the cytotoxic capabilities and migratory capacity of CD8+ T cells, subsequently leading to an increased expression of effector molecules within the tumor, such as IFNγ, GzmB, TNFα, and T-bet. Here, CD8A is linked to neoplasm.